Canada markets closed

Relmada Therapeutics, Inc. (RLMD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.8300+0.1300 (+3.51%)
At close: 04:00PM EDT
3.8300 0.00 (0.00%)
After hours: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 115.57M
Enterprise Value 19.24M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.35
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.19

Trading Information

Stock Price History

Beta (5Y Monthly) 0.19
52-Week Change 340.81%
S&P500 52-Week Change 322.36%
52 Week High 37.2230
52 Week Low 32.3600
50-Day Moving Average 35.1188
200-Day Moving Average 33.6882

Share Statistics

Avg Vol (3 month) 3213.33k
Avg Vol (10 day) 3111.44k
Shares Outstanding 530.17M
Implied Shares Outstanding 630.17M
Float 825.71M
% Held by Insiders 18.04%
% Held by Institutions 146.30%
Shares Short (Apr 15, 2024) 41.71M
Short Ratio (Apr 15, 2024) 48.63
Short % of Float (Apr 15, 2024) 45.76%
Short % of Shares Outstanding (Apr 15, 2024) 45.66%
Shares Short (prior month Mar 15, 2024) 41.75M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Sept 30, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:4
Last Split Date 3Sept 30, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-51.76%
Return on Equity (ttm)-87.51%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-98.79M
Diluted EPS (ttm)-3.2800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)96.32M
Total Cash Per Share (mrq)3.19
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)8.00
Book Value Per Share (mrq)2.84

Cash Flow Statement

Operating Cash Flow (ttm)-51.66M
Levered Free Cash Flow (ttm)-17.91M